By Nick Stride
Friday 16th November 2001 |
Text too small? |
![]() |
F&P Healthcare American Depositary Shares finished Wednesday's Nasdaq market trading at $US26.05, a gain of 44.7% on the $US18 at which they were sold to US and other institutions on Tuesday.
F&P chief executive Gary Paykel earlier this month rejected criticism from institutional shareholders and sharebroking analysts that the $US16-18 an ADS "indicative price" it had set for the sale of 17.6 million Healthcare shares was far too low.
At $US26.05 the shares sold had gained $35 million ($83.5 million) in value in two days.
Arcus Investment Management's Simon Botherway said the sale, as predicted, had resulted in "a massive value transfer from Australasian investors to North American investors. I can assure you I'm not the only person who's extremely unhappy with this."
Fund managers Alliance Capital, BT Funds Management and New Zealand Funds Management and sharebroker Credit Suisse First Boston had also warned the float was too cheaply priced.
Healthcare shares were trading on the local market today at $15.70, up from the $10.95 at which the float price valued them.
No comments yet
PaySauce Quarterly Market Update - June 2024
Manawa Energy - Annual Meeting and Director Nominations
SKO - Annual Shareholders Meeting Materials
VGL - 2024 Half Year Results Announcement Date
TruScreen Group Limited ("TRU") - Late Annual Report
ARB - Sale of In Vitro Business
NZK - Change of External Auditor
SCT - Scott lands major contracts for MHL in Europe
July 2nd Morning Report
PFI - Details of FP24 Results Webcast